News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
David Fajgenbaum: Can’t wait for our annual Castleman meeting tonight!
Photo taken from David Fajgenbaum/Twitter
Dec 15, 2023, 06:34

David Fajgenbaum: Can’t wait for our annual Castleman meeting tonight!

David Fajgenbaum, Founding Director of the Center for Cytokine Storm Treatment and Laboratory, shared on X/Twitter:

“So good to see Naveen Pemmaraju at The American Society of Hematology (ASH)! Can’t wait for our annual Castleman meeting tonight!”

For details, click here.
Source: David Fajgenbaum/X

American Society of Hematology (ASH) cancer Castleman Center for Cytokine Storm Treatment and Laboratory David Fajgenbaum OncoDaily Oncology
Blog
Jul 4, 2024, 16:27
Richard Scott: Exciting to see research carried out via the NHS Genomic Medicine Service
Blog
Jul 4, 2024, 16:15
POLARIS has been named a finalist for the Langland Award for Excellence in Healthcare Partnership
Blog
Jul 4, 2024, 16:09
A deep dive into immune responses to cancer vaccines plus immunotherapy - Dana-Farber Cancer Institute
Insight
Jul 4, 2024, 15:48
Stefano Cinti: Another small but important step towards our goal of liquid biopsy on chip
Blog
Jul 4, 2024, 15:34
Justin Stebbing: Excited to be a communicating author with benefits to patients with "cold tumours"
Insight
Jul 4, 2024, 15:05
Susanna Greer: Next target - neuroblastoma
Blog
Jul 4, 2024, 15:00
iOmx Therapeutics Appoints Florian Schmid as New Chief Financial Officer
Insight
Jul 4, 2024, 14:44
Elizabeth McKenna: The July issue of Cancer Discovery is now online
Insight
Jul 4, 2024, 14:21
A critical appraisal of the long-term follow-up of CASSIOPEIA trial by Manni Mohyuddin
Blog
Jul 4, 2024, 14:19
David Zaas: Historic project for the next phase of the Salem Parkway Multi-Use Path
Insight
Jul 4, 2024, 14:15
Evolution of HR+/HER2- breast cancer during exposure to neoadjuvant chemotherapy and endocrine treatment
Blog
Jul 4, 2024, 14:08
Oncology Brothers: Starting the morning with Dr. Jason Zittel